---
category: news
title: "Focus On - Feature, In Depth"
excerpt: "Calling MIG a leading German venture capital (VC) investment firm and one with a focus on life sciences and deep tech companies, might not do justice to the key role that it is playing in advancing some of Europeâ€™s most promising biotech start-ups."
publishedDateTime: 2022-05-26T08:28:00Z
originalUrl: "https://www.thepharmaletter.com/listing/focus-on/feature-in-depth?tagid[]=18884&tagid[]=38441"
webUrl: "https://www.thepharmaletter.com/listing/focus-on/feature-in-depth?tagid[]=18884&tagid[]=38441"
type: article
quality: 4
heat: 4
published: false

provider:
  name: The Pharma Letter
  domain: thepharmaletter.com

topics:
  - AI in Healthcare
  - AI

secured: "1Z04IA2QvwLHcF+Q8mVhlMqsH+LFc0HDyYEWMFhRgAbz2+aNcIWZ9IvsNbpO45zfeUNaGHfXJt/RywJ2A569Z8QqN7ibGCmpqtGtKVkFZSYHDpWp4gmCwXwEU3J+3GSx+wKxtxyeWAkJxvCk52P+7INYNoa37j6JhGaCnAn7iVjk4gJfE9TD7RF9lKvEwvo6EOTYTA8lOvq1e5bPsTc2D/DSbZJl8GKxbq5/2LsPK2T4qiaGN+llbDkDt3egrdwzM/pg1cdT5sfzDw1APKBEp5X4DAhMtmFVT9sSmd9I48S+Y1V2zT0WRAHSzxsqmKARSTRrc0pMR9W6PjIQar9obW+kWf+ujZtWKtmqKhkWtF4=;pBOrHmxb6KaZKBDjVPk1jQ=="
---

